Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
20,695,182
-
Share change
-
-3,605,001
-
Total reported value
-
$1,688,417,367
-
Put/Call ratio
-
105%
-
Price per share
-
$81.52
-
Number of holders
-
183
-
Value change
-
-$282,174,671
-
Number of buys
-
107
-
Number of sells
-
78
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q4 2020
As of 31 Dec 2020,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,695,182 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Artisan Partners Limited Partnership, Artal Group S.A., BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, Redmile Group, LLC, Temasek Holdings (Private) Ltd, and AMERIPRISE FINANCIAL INC.
This page lists
183
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.